President Bush is balking at a new series of campaign commercials are operating outside new campaign finance laws.
Is this the future of presidential election advertising? We’ll ask Ed Gillespie, chairman of the Republican National Committee, and Ellen Malcolm, president of Emily's List.
U.S. casualties in Iraq are now at their lowest level since the war began. Can this good news continue? We’ll ask retired U.S. Army Col. David Hunt, FNC military analyst.
The latest servicing mission to the Hubble Space Telescope has been called off, leaving some questioning NASA's latest move. Should the Hubble be saved? Dr. Bruce Margon, associate director for science at the Space Telescope Science Institute, and John Pike, director of GlobalSecurity.org, join the debate.
Four years ago the Nasdaq hit its record high. Then the bottom fell out. Where do we go from here? We’ll ask Gregg Hymowitz, founder of Entrust Capital, and John "Bradshaw" Layfield, WWE superstar and author of "Have More Money Now."
A new drug could help you fight off any excess calories from those donuts and quit smoking at the same time. Sounds too good to be true? We’ll ask Russell Ellison, chief medical officer at Sanofi Synthelabo, the French drug-maker financing the drug.
About the Show
More than just facts and figures, "Your World with Cavuto" gets to the heart of the matter with in-depth reporting from Dagen McDowell, FOX Business correspondent, and analysis from our FOX Business News All-Stars: